These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19947419)

  • 21. Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage.
    Ducruet AF; Hickman ZL; Zacharia BE; Grobelny BT; Narula R; Guo KH; Claassen J; Lee K; Badjatia N; Mayer SA; Connolly ES
    Neurosurgery; 2010 Apr; 66(4):648-55. PubMed ID: 20305489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR-III IHV) trial.
    Dey M; Stadnik A; Riad F; Zhang L; McBee N; Kase C; Carhuapoma JR; Ram M; Lane K; Ostapkovich N; Aldrich F; Aldrich C; Jallo J; Butcher K; Snider R; Hanley D; Ziai W; Awad IA;
    Neurosurgery; 2015 Mar; 76(3):291-300; discussion 301. PubMed ID: 25635887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography--guided pilot study.
    Sekoranja L; Loulidi J; Yilmaz H; Lovblad K; Temperli P; Comelli M; Sztajzel RF
    Stroke; 2006 Jul; 37(7):1805-9. PubMed ID: 16763175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraventricular tissue plasminogen activator toxicity.
    Gaberel T; Emery E
    Neurosurgery; 2011 Jan; 68(1):E288-9; author reply E289. PubMed ID: 21150745
    [No Abstract]   [Full Text] [Related]  

  • 25. Real-time monitoring of recanalization after intravenous thrombolysis for acute ischemic stroke.
    Delgado-Mederos R; Ribó M; Montaner J; Arenillas JF; Rubiera M; Alvarez-Sabín J; Molina CA
    Eur J Neurol; 2006 Apr; 13(4):426-7. PubMed ID: 16643326
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of intraventricular hemorrhage with intraventricular administration of recombinant tissue plasminogen activator A clinical study of 18 cases.
    Vereecken KK; Van Havenbergh T; De Beuckelaar W; Parizel PM; Jorens PG
    Clin Neurol Neurosurg; 2006 Jul; 108(5):451-5. PubMed ID: 16139422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
    [No Abstract]   [Full Text] [Related]  

  • 28. Traumatic intraventricular hemorrhage treated with intraventricular recombinant-tissue plasminogen activator: technical case report.
    Grabb PA
    Neurosurgery; 1998 Oct; 43(4):966-9. PubMed ID: 9766330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timing of recanalization after microbubble-enhanced intravenous thrombolysis in basilar artery occlusion.
    Pagola J; Ribo M; Alvarez-Sabín J; Lange M; Rubiera M; Molina CA
    Stroke; 2007 Nov; 38(11):2931-4. PubMed ID: 17901389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraventricular administration of human recombinant plasminogen activator for posthemorrhagic hydrocephalus of the newborn.
    Nowak S; Rudecka M; Polis L
    Acta Paediatr; 1999 Mar; 88(3):348-9. PubMed ID: 10229053
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of intraventricular fibrinolytic therapy with rt-PA on the long-term outcome of treated patients with spontaneous basal ganglia hemorrhage: a case-control study.
    Huttner HB; Tognoni E; Bardutzky J; Hartmann M; Köhrmann M; Kanter IC; Jüttler E; Schellinger PD; Schwab S
    Eur J Neurol; 2008 Apr; 15(4):342-9. PubMed ID: 18312407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial.
    Daffertshofer M; Gass A; Ringleb P; Sitzer M; Sliwka U; Els T; Sedlaczek O; Koroshetz WJ; Hennerici MG
    Stroke; 2005 Jul; 36(7):1441-6. PubMed ID: 15947262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of left ventricular assist device thrombosis with extended catheter-directed intraventricular thrombolytic therapy.
    Thenappan T; Anderson AS; Jeevanadham V; Rich JD; Shah AP
    Circ Heart Fail; 2013 May; 6(3):e27-9. PubMed ID: 23694774
    [No Abstract]   [Full Text] [Related]  

  • 34. Intraventricular administration of recombinant tissue plasminogen activator for intraventricular hemorrhage in the newborn.
    Akisu M; Yalaz M; Arslanoglu S; Kultursay N
    Neurosurg Rev; 2003 Oct; 26(4):266-8. PubMed ID: 12802693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of thrombolysis with intravenous alteplase for acute ischemic stroke in older adults.
    Dirks M; Koudstaal PJ; Dippel DW; Niessen LW; van Wijngaarden JD; Franke CL; van Oostenbrugge RJ
    J Am Geriatr Soc; 2011 Nov; 59(11):2169-71. PubMed ID: 22098036
    [No Abstract]   [Full Text] [Related]  

  • 36. [Thrombolytic therapy: formation and current practice of intravenous thrombolysis in acute ischemic stroke].
    Iavorskaia VA; Flomin IuV; D'olog NV; Grebeniuk AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; Suppl 15():13-27. PubMed ID: 16447549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I study of intraventricular recombinant tissue plasminogen activator for treatment of posthaemorrhagic hydrocephalus.
    Whitelaw A; Saliba E; Fellman V; Mowinckel MC; Acolet D; Marlow N
    Arch Dis Child Fetal Neonatal Ed; 1996 Jul; 75(1):F20-6. PubMed ID: 8795351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraventricular hemorrhage: harmful effect is not from the pressure alone.
    Lee K; Claassen J
    Cerebrovasc Dis; 2009; 27(4):411-2. PubMed ID: 19295202
    [No Abstract]   [Full Text] [Related]  

  • 39. The timing of thrombolysis for strokes complicating cardiac catheterization.
    De Marco F; Routledge H; Lefèvre T
    J Am Coll Cardiol; 2008 Jul; 52(4):317; author reply 317-8. PubMed ID: 18634993
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment with tPA predicts better outcome even if MCA occlusion persists.
    Kablau M; Alonso A; Hennerici MG; Fatar M
    Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.